Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Sickle Cell Disease 2016 NIAID 5R01AI110618-02 Pneumococcal pathogenesis in sickle cell disease ROSCH, JASON ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $445,000
Sickle Cell Disease 2016 NHLBI 5K23HL119557-02 Improving Pain in Sickle Cell Patients With Targeted Antithrombotic Therapy SHAH, NIRMISH DUKE UNIVERSITY NC $157,929
Sickle Cell Disease 2016 NHLBI 5K25HL121192-03 MRI-based Quantitative Brain Perfusion Mapping for Sickle Cell Disease QIN, QIN HUGO W. MOSER RES INST KENNEDY KRIEGER MD $161,457
Sickle Cell Disease 2016 NHLBI 5R01HL106192-06 Mechanisms of endothelial barrier phenotypes in sickle cell disease OFORI-ACQUAH, SOLOMON UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $495,110
Sickle Cell Disease 2016 NHLBI 4R01HL112603-05 Hemostatic factors and sickle cell disease MALIK, PUNAM CINCINNATI CHILDRENS HOSP MED CTR OH $382,500
Sickle Cell Disease 2016 NIEHS 4R01ES020875-05 De novo CNV formation in vivo with sickle cell anemia therapy GLOVER, THOMAS UNIVERSITY OF MICHIGAN MI $345,028
Sickle Cell Disease 2016 NIMHD 5T37MD008639-03 HEALTH DISPARITIES RESEARCH THROUGH INTERNATIONAL EXCHANGE ANDERSON, WINSTON HOWARD UNIVERSITY DC $255,919
Sickle Cell Disease 2016 NIDDK 4R01DK052962-13 Novel Globin Gene Modulators PERRINE, SUSAN BOSTON UNIVERSITY MEDICAL CAMPUS MA $356,048
Sickle Cell Disease 2016 NIDDK 5R01DK100595-03 Regulation of Globin Gene Switching by O-GlcNAc Post-Translational Modification PETERSON, KENNETH UNIVERSITY OF KANSAS MEDICAL CENTER KS $262,740
Sickle Cell Disease 2016 NHLBI 4R01HL111659-05 Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy ATAGA, KENNETH UNIV OF NORTH CAROLINA CHAPEL HILL NC $474,581
Sickle Cell Disease 2016 NHLBI 5R01HL121264-03 Endothelialized microfluidics for sickle cell disease research & drug discovery LAM, WILBUR EMORY UNIVERSITY GA $390,164
Sickle Cell Disease 2016 NCI 4R01CA166054-04 Effect of anti-S phase agents on human chromosomes DUTTA, ANINDYA UNIVERSITY OF VIRGINIA VA $327,850
Sickle Cell Disease 2016 NHLBI 4R01HL111969-05 Biomarkers of Inflammation and Vaso-occlusion in Sickle Cell Disease LINDEN, JOEL LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $799,323
Sickle Cell Disease 2016 NHLBI 4R01HL112633-05 von Willebrand Factor in Sickle Cell Disease Pathophysiology LOPEZ, JOSE PUGET SOUND BLOOD CENTER WA $729,091
Sickle Cell Disease 2016 NHLBI 5F31HL126353-02 Translating Transplant Practices for Sickle Cell Disease in the US and France: National Commitments, Institutional Regimens, Private Sentiments JAE, GINA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $14,275
Sickle Cell Disease 2016 NHLBI 4R01HL111656-04 Vascular-targeted genomic and genetic strategies for acute chest syndrome MACHADO, ROBERTO UNIVERSITY OF ILLINOIS AT CHICAGO IL $513,649
Sickle Cell Disease 2016 NHLBI 1R01HL130139-01 Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization YAZDANBAKHSH, KARINA NEW YORK BLOOD CENTER NY $426,500
Sickle Cell Disease 2016 NIDDK 1R01DK107807-01 Opiorphin as a master regulator of pathways leading to priapism DAVIES, KELVIN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $488,475
Sickle Cell Disease 2016 NHLBI 5R01HL125005-03 Inhibition of HIV-1 in Sickle Cell Disease NEKHAI, SERGEI HOWARD UNIVERSITY DC $433,249
Sickle Cell Disease 2016 NHLBI 1R21HL130818-01 Dissecting the origins of fetal hemoglobin modulation of sickle cell vaso-occlusion WOOD, DAVID UNIVERSITY OF MINNESOTA MN $242,670
Sickle Cell Disease 2016 NHLBI 1K01HL125495-01A1 Identification of Predictors and Outcomes of Sickle Cell Health Care Transition PORTER, JERLYM ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $153,954
Sickle Cell Disease 2016 NHLBI 5K23HL119627-03 Erythrocyte Nitric Oxide Links Rheology and Vasculopathy in Sickle Cell Disease DETTERICH, JON CHILDREN'S HOSPITAL OF LOS ANGELES CA $185,702
Sickle Cell Disease 2016 NHLBI 5K08HL125100-02 Sickle Cell Trait: An overlooked genetic modifier of disease in African-Americans NAIK, RAKHI JOHNS HOPKINS UNIVERSITY MD $171,310
Sickle Cell Disease 2016 NHLBI 4R01HL113574-04 Metabolites, Sickle Cell Disease, and Novel Therapeutics XIA, YANG UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $380,000
Sickle Cell Disease 2016 NHLBI 5R01HL032259-34 Molecular Analysis of Normal and Thalassemic DNA ORKIN, STUART CHILDREN'S HOSPITAL CORPORATION MA $442,500
Sickle Cell Disease 2016 NHLBI 5K23HL127100-02 Chronobiology and Chronopharmacology to Prevent Sickle Cell Nephropathy LEBENSBURGER, JEFFREY UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $191,145
Sickle Cell Disease 2016 NINDS 5R01NS070711-07 Nociceptive Mechanisms Underlying Sickle Cell Pain STUCKY, CHERYL MEDICAL COLLEGE OF WISCONSIN WI $382,145
Sickle Cell Disease 2016 NHLBI 4R01HL111372-05 PlGF-HIF1a-miRNA Axis in Sickle Pulmonary Hypertension KALRA, VIJAY UNIVERSITY OF SOUTHERN CALIFORNIA CA $618,630
Sickle Cell Disease 2016 NICHD 5R44HD075429-03 Twice-Weekly Subcutaneous Liposome Chelator to Treat Transfusional Iron Overload HAYES, MARK ZONEONE PHARMA, INC. CA $956,715
Sickle Cell Disease 2016 NIMHD 1R43MD010746-01 PINPOINT: Gaming technology to engage adolescent sickle cell patients in precision pain management MYERS, VALERIE KLEIN BUENDEL, INC. CO $226,154
Sickle Cell Disease 2016 NHLBI 1R43HL131158-01 Stabilized Prasugrel enantiomers for pediatric sickle cell disease DEWITT, SHEILA DEUTERX, LLC NH $294,508
Sickle Cell Disease 2016 NIDA 9R44DA042465-02 A NOVEL APPROACH FOR PAIN TREATMENT WITHOUT OPIOID LIABILITIES ZAVERI, NURULAIN ASTRAEA THERAPEUTICS, LLC CA $760,015
Sickle Cell Disease 2016 NHLBI 1F32HL131216-01 Pulmonary arteriole micro-embolism by platelet-neutrophil aggregates promotes sickle cell disease acute chest syndrome BENNEWITZ, MARGARET UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $37,522
Sickle Cell Disease 2016 NIDDK 1F32DK108493-01 Characterization of TR2 and TR4 homodimer and heterodimer transcriptional mechanisms during erythropoiesis. LEE, MARY UNIVERSITY OF MICHIGAN MI $56,118
Sickle Cell Disease 2016 NIDDK 5R01DK100692-03 Genetic Modifiers of Beta-like Globin Gene Switching PETERS, LUANNE JACKSON LABORATORY ME $393,750
Sickle Cell Disease 2016 NHLBI 2R44HL119086-02 Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease SWIFT, ROBERT INVENUX, LLC CO $807,410
Sickle Cell Disease 2016 NHLBI 4R37HL058091-20 Effects of Nitric Oxide in Sickle Cell Blood KIM-SHAPIRO, DANIEL WAKE FOREST UNIVERSITY NC $353,184
Sickle Cell Disease 2016 NIMHD 5R01MD009124-03 Hemoglobin Modifiers for Sickle Cell Disease Therapy SAFO, MARTIN VIRGINIA COMMONWEALTH UNIVERSITY VA $395,866
Sickle Cell Disease 2016 NIGMS 5P20GM109021-03 5230 Adminsitrative Core STUART, MARIE ALFRED I. DU PONT HOSP FOR CHILDREN DE $375,431
Sickle Cell Disease 2016 NIGMS 5P20GM109021-03 5231 Clinical and Data Management Core KOLB, EDWARD ALFRED I. DU PONT HOSP FOR CHILDREN DE $187,789
Sickle Cell Disease 2016 NIGMS 5P20GM109021-03 5232 Gene Editing of the Beta Globin Gene Using TAL Effector Nucleases and single stranded oligonucleotides MAN, DULA ALFRED I. DU PONT HOSP FOR CHILDREN DE $244,042
Sickle Cell Disease 2016 NIGMS 5P20GM109021-03 5233 Role of Inflammation in SCD-related Pain in Children with Sickle Cell Disease MILLER, ROBIN ALFRED I. DU PONT HOSP FOR CHILDREN DE $726,346
Sickle Cell Disease 2016 NIGMS 5P20GM109021-03 5234 Screening for Psychosocial Risk in Pediatric Sickle Cell Disease READER, STEVEN ALFRED I. DU PONT HOSP FOR CHILDREN DE $302,215
Sickle Cell Disease 2016 NIGMS 5P20GM109021-03 5235 Identifying Genetic Predictors of Stroke Using Next Generation Sequencing KOLB, EDWARD ALFRED I. DU PONT HOSP FOR CHILDREN DE $70,139
Sickle Cell Disease 2016 NIGMS 5P20GM109021-03 5236 In vitro Growth of Stem Cells on Nanofiber Scaffolds WINSTEAD, CHERESE ALFRED I. DU PONT HOSP FOR CHILDREN DE $75,497
Sickle Cell Disease 2016 NHLBI 5R01HL121415-03 T cell Immunoregulation of alloimmunization in sickle cell disease YAZDANBAKHSH, KARINA NEW YORK BLOOD CENTER NY $617,404
Sickle Cell Disease 2016 NIDDK 5R01DK089439-06 Novel regulators of stress erythropoiesis WOJCHOWSKI, DON MAINE MEDICAL CENTER ME $341,247
Sickle Cell Disease 2016 NHLBI 5R34HL122557-02 Arginine therapy for the treatment of pain in children with sickle cell disease MORRIS, CLAUDIA EMORY UNIVERSITY GA $197,282
Sickle Cell Disease 2016 NHLBI 5F32HL123251-03 The Role of the Thyroid Hormone Signaling Pathway in Globin Switching WILEY, DAVID CHILDREN'S HOSPITAL CORPORATION MA $59,970
Sickle Cell Disease 2016 NHLBI 4K12HL087107-10 CLINICAL HEMATOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM AT WASHINGTON UNIVERSITY SADLER, J WASHINGTON UNIVERSITY MO $389,734
Sickle Cell Disease 2016 NHLBI 4R01HL048801-24 Embryonic Hematopoiesis ZON, LEONARD CHILDREN'S HOSPITAL CORPORATION MA $435,000
Sickle Cell Disease 2016 NHLBI 5R01HL069234-12 Gamma Globin Induction: Molecular and Cell-Based Strategies PACE, BETTY GEORGIA REGENTS UNIVERSITY GA $432,219
Sickle Cell Disease 2016 NHLBI 4R01HL119479-04 Functions, mechanisms, and therapeutic potential of chromatin looping BLOBEL, GERD CHILDREN'S HOSP OF PHILADELPHIA PA $531,151
Sickle Cell Disease 2016 NIDDK 5F30DK103359-02 Identification of Novel Regulators of Fetal Hemoglobin Expression CANVER, MATTHEW HARVARD MEDICAL SCHOOL MA $48,576
Sickle Cell Disease 2016 NHLBI 4R01HL111264-04 Mechanisms of HbF Activation by Non-deletional HPFH PETERSON, KENNETH UNIVERSITY OF KANSAS MEDICAL CENTER KS $377,500
Sickle Cell Disease 2016 NHLBI 4K23HL112848-04 Platelet TSP1 Mediates Vascular Disease and pulmonary hypertension in Sickle Cell NOVELLI, ENRICO UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $166,104
Sickle Cell Disease 2016 NHLBI 4P01HL114457-04 6757 Equilibrative Nucleoside Transporters during AKI ELTZSCHIG, HOLGER UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $536,571
Sickle Cell Disease 2016 NHLBI 4P01HL114457-04 6758 Novel Roles of the Erythrocyte in the Hypoxic Adenosine Response XIA, YANG UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $536,393
Sickle Cell Disease 2016 NHLBI 4K23HL114636-04 Peripheral Sensitization as a Novel Mechanism for Pain in Sickle Cell Disease BRANDOW, AMANDA MEDICAL COLLEGE OF WISCONSIN WI $166,860
Sickle Cell Disease 2016 NIGMS 4R01GM024417-37 Regulation of Erythrocyte Function LOW, PHILIP PURDUE UNIVERSITY IN $451,822
Sickle Cell Disease 2016 NHLBI 4U01HL117658-04 Improving HbF induction by inhibiting epigenetic target enzymes ENGEL, JAMES UNIVERSITY OF MICHIGAN MI $1,736,085
Sickle Cell Disease 2016 NHLBI 4U01HL117720-04 Translational and clinical studies targeting y-globin modulation WILLIAMS, DAVID CHILDREN'S HOSPITAL CORPORATION MA $1,483,445
Sickle Cell Disease 2016 NHLBI 4U01HL117659-04 Targeted Anticoagulant Therapy for Sickle Cell Disease ATAGA, KENNETH UNIV OF NORTH CAROLINA CHAPEL HILL NC $1,481,743
Sickle Cell Disease 2016 NHLBI 4U01HL117709-04 Cincinnati Center of Excellence in Hemoglobinopathies Research MALIK, PUNAM CINCINNATI CHILDRENS HOSP MED CTR OH $1,784,042
Sickle Cell Disease 2016 NHLBI 4U01HL117718-04 Multimodal biophysical markers of vascular disease in hemoglobinopathies COATES, THOMAS CHILDREN'S HOSPITAL OF LOS ANGELES CA $1,913,722
Sickle Cell Disease 2016 NHLBI 4U01HL117721-04 Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease JOINER, CLINTON EMORY UNIVERSITY GA $1,909,806
Sickle Cell Disease 2016 NHLBI 5R01HL124945-03 HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease MOLOKIE, ROBERT UNIVERSITY OF ILLINOIS AT CHICAGO IL $827,237
Sickle Cell Disease 2016 NHLBI 4U01HL114476-04 Multiscale Modeling of Sickle Cell Anemia: Methods and Validation KARNIADAKIS, GEORGE BROWN UNIVERSITY RI $766,379
Sickle Cell Disease 2016 NIDDK 1R01DK108803-01 Metabolomics and Genomics in African Americans with CKD GRAMS, MORGAN JOHNS HOPKINS UNIVERSITY MD $635,535
Sickle Cell Disease 2016 NINDS 1R01NS096127-01 MRI-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia JORDAN, LORI VANDERBILT UNIVERSITY TN $22,339
Sickle Cell Disease 2016 NHLBI 1K01HL132057-01 Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease REEVES, SARAH UNIVERSITY OF MICHIGAN MI $119,880
Sickle Cell Disease 2016 NHLBI 5F31HL128088-02 Sickle Cell Disease Associated with Pulmonary Hypertension: Mechanical and Hemodynamic Consequences SCHREIER, DAVID UNIVERSITY OF WISCONSIN-MADISON WI $32,017
Sickle Cell Disease 2016 NHLBI 4U01HL117684-04 The Role of Endothelin-1 in Sickle Cell Disease KUTLAR, ABDULLAH GEORGIA REGENTS UNIVERSITY GA $1,630,437
Sickle Cell Disease 2016 NIDDK 1R03DK109232-01 Identification of sequences and factors required for HbF repression BAUER, DANIEL CHILDREN'S HOSPITAL CORPORATION MA $88,500
Sickle Cell Disease 2016 NHLBI 5R01HL069438-15 Adhesion Mechanisms Mediating Sickle Cell Vasooclusion In Vivo FRENETTE, PAUL ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $417,500
Sickle Cell Disease 2016 NHLBI 4K23HL119351-04 Inhaled Mometasone to Promote Reduction in Vaso-occlusive Events (IMPROVE) GLASSBERG, JEFFREY ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $192,201
Sickle Cell Disease 2016 NHLBI 4U01HL117664-04 Cannabinoid-based therapy and approaches to quantify pain in sickle cell disease GUPTA, KALPNA UNIVERSITY OF MINNESOTA MN $1,869,191
Sickle Cell Disease 2016 NHLBI 1R01HL128371-01A1 Mechanisms of Inflammation in Sickle Cell Disease PRITCHARD, KIRKWOOD MEDICAL COLLEGE OF WISCONSIN WI $520,851
Sickle Cell Disease 2016 NHLBI 1R01HL127107-01A1 Neurovascular Determinants of Cognitive Function in Adults with Sickle Cell Disease NOVELLI, ENRICO UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $751,612
Sickle Cell Disease 2016 NIDDK 5F30DK107055-02 Therapeutic potential and broader applicability of forced chromatin looping GREVET, JEREMY UNIVERSITY OF PENNSYLVANIA PA $30,400
Sickle Cell Disease 2016 NHLBI 5P01HL122173-02 8121 Project 1: Cell Therapy for Correction of Blood Disorders STORB, RAINER FRED HUTCHINSON CANCER RESEARCH CENTER WA $477,530
Sickle Cell Disease 2016 NHLBI 9R01HL135895-16A1 Cannabinoid Modulation of Hyperalgesia SIMONE, DONALD UNIVERSITY OF MINNESOTA MN $493,069
Sickle Cell Disease 2016 NIDDK 5R21DK106509-02 Factor XIII and Fibrinogen: Mechanisms of Genetic Risk in SCD-Related Priapism TELEN, MARILYN DUKE UNIVERSITY NC $195,250
Sickle Cell Disease 2016 NICHD 1R21HD084810-01A1 “ Improving Self-Management in Adolescents with Sickle Cell Disease” CROSBY, LORI CINCINNATI CHILDRENS HOSP MED CTR OH $234,000
Sickle Cell Disease 2016 NHLBI 5R01HL121386-03 Characterizing mechanisms of sickle cell crisis via dynamic optical assay SO, PETER MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $537,512
Sickle Cell Disease 2016 NIMHD 5R01MD009162-02 SCN5A gene and prolonged QT in sickle cell disease MAHER, JOSEPH UNIVERSITY OF MISSISSIPPI MED CTR MS $91,137
Sickle Cell Disease 2016 NIGMS 5R01MD009162-02 SCN5A gene and prolonged QT in sickle cell disease MAHER, JOSEPH UNIVERSITY OF MISSISSIPPI MED CTR MS $266,166
Sickle Cell Disease 2016 NHLBI 1R21HL129047-01A1 Pulmonary Hypertension Associated with Sickle Cell Disease CHESLER, NAOMI UNIVERSITY OF WISCONSIN-MADISON WI $203,000
Sickle Cell Disease 2016 NIDDK 4K08DK093705-05 Epigenetic regulation of BCL11A in the hemoglobin switch BAUER, DANIEL CHILDREN'S HOSPITAL CORPORATION MA $156,276
Sickle Cell Disease 2016 NHLBI 1R34HL127162-01A1 Hydroxyurea Management in Kids: Intensive versus Stable Dosage Strategies (HUGKISS) ESTEPP, JEREMIE ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $413,685
Sickle Cell Disease 2016 NHLBI 4R18HL112737-05 Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators SMITH, WALLY VIRGINIA COMMONWEALTH UNIVERSITY VA $594,619
Sickle Cell Disease 2016 NIDDK 5F30DK107194-02 Novel Mechanisms of Decreased NO Bioavailability in Sickle Cell Nephropathy FOX, BRANDON UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $33,714
Sickle Cell Disease 2016 NHLBI 5R21HL123641-02 Genetic Modifiers of Transfusional Iron Overload FLANAGAN, JONATHAN BAYLOR COLLEGE OF MEDICINE TX $129,105
Sickle Cell Disease 2016 NHLBI 5R01HL129241-02 MR-Derived Cerebral Blood Flow and Oxygen Metabolism to Stratify Stroke Risk in Pediatric Sickle Cell Disease FORD, ANDRIA WASHINGTON UNIVERSITY MO $534,896
Sickle Cell Disease 2016 NHLBI 5R01HL128297-02 Pulmonary arteriole occlusion by platelet-neutrophil micro-emboli in Acute Chest Syndrome SUNDD, PRITHU UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $373,876
Sickle Cell Disease 2016 NHLBI 1F32HL132539-01 Pharmacologic Induction of Cytoprotection in Sickle Cell Disease IHUNNAH, CHIBUEZE UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $60,618
Sickle Cell Disease 2016 NHLBI 4P50HL110790-05 A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia NATHAN, DAVID DANA-FARBER CANCER INST MA $2,004,198
Sickle Cell Disease 2016 NHLBI 5R34HL128798-02 A Pilot Study of N-acetylcysteine in Sickle Cell Disease Vaso-Occlusive Crisis KONKLE, BARBARA PUGET SOUND BLOOD CENTER WA $397,499
Sickle Cell Disease 2016 NHLBI 5U01HL128566-02 Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center KRISHNAMURTI, LAKSHMANAN EMORY UNIVERSITY GA $1,454,461
Sickle Cell Disease 2016 NHLBI 5R25HL128640-02 Pittsburgh Intensive Training in Hematology Research OFORI-ACQUAH, SOLOMON UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $76,494
Sickle Cell Disease 2016 NHLBI 5U01HL128568-02 Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC EAPEN, MARY MEDICAL COLLEGE OF WISCONSIN WI $294,286
Sickle Cell Disease 2016 NHLBI 2R01HL098141-05 Protein kinase mechanisms for chronic pain in sickle cell disease WANG, ZAIJIE JIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $404,011
Sickle Cell Disease 2016 NHLBI 4P50HL118006-04 Center for Hemoglobin Research in Minorities (CHaRM) TAYLOR, ROBERT HOWARD UNIVERSITY DC $1,427,955
Sickle Cell Disease 2016 NHLBI 5R43HL124897-02 HLS-Small Molecule Discovery at Novel Target for Fetal Hemoglobin Induction THACHER, SCOTT ORPHAGEN PHARMACEUTICALS CA $160,677
Sickle Cell Disease 2016 NHLBI 5K23HL125984-02 Genetics and Genomics of Sickle Cell Nephropathy. SARAF, SANTOSH UNIVERSITY OF ILLINOIS AT CHICAGO IL $185,152
Sickle Cell Disease 2016 NHLBI 5K23HL127303-02 A multidimensional strategy to improve hydroxyurea adherence in children with sickle cell CREARY, SUSAN RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $158,948
Sickle Cell Disease 2016 NHLBI 5K23HL128885-02 Therapeutic Response Evaluation and Adherence Trial: A Prospective Study of Hydroxyurea for Children with Sickle Cell Anemia MCGANN, PATRICK CINCINNATI CHILDRENS HOSP MED CTR OH $189,000
Sickle Cell Disease 2016 NHLBI 3R01HL069234-11S1 Gamma Globin Induction: Molecular and Cell-Based Strategies PACE, BETTY GEORGIA REGENTS UNIVERSITY GA $17,472
Sickle Cell Disease 2016 FIC 6R01NS094041-02 Primary prevention of stroke in children with SCD in Sub-Saharan Africa II DEBAUN, MICHAEL VANDERBILT UNIVERSITY MEDICAL CENTER TN $10,000
Sickle Cell Disease 2016 NINDS 6R01NS094041-02 Primary prevention of stroke in children with SCD in Sub-Saharan Africa II DEBAUN, MICHAEL VANDERBILT UNIVERSITY MEDICAL CENTER TN $1,140,318
Sickle Cell Disease 2016 NIDDK 5R01DK052356-21 Structure and function of the human beta-globin locus control region BUNGERT, JORG UNIVERSITY OF FLORIDA FL $329,086
Sickle Cell Disease 2016 NIDDK 5F32DK105673-02 Correcting the beta-globin mutation in iPS cells for treatment of sickle cell disease. MOSENSON, JEFFREY UNIVERSITY OF ILLINOIS AT CHICAGO IL $56,118
Sickle Cell Disease 2016 NIDDK 5DP1DK105602-03 Engineering epigenetic therapy for sickle cell disease NOVINA, CARL DANA-FARBER CANCER INST MA $865,000
Sickle Cell Disease 2016 NIBIB 4P41EB001978-32 7621 Models of Multi-Factor Disorders in Cardiorespiratory Control KHOO, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $180,338
Sickle Cell Disease 2016 NHLBI 1R43HL131065-01A1 Oral Carbon Monoxide Therapeutic to Prevent Vaso-Occlusive Crises in Sickle Cell Disease GOMPERTS, EDWARD HILLHURST BIOPHARMACEUTICALS, INC. CA $258,257
Sickle Cell Disease 2016 NINR 5R21NR015283-02 Subjective Responses and Metabolic State during Exercise in SIckle Cell Anemia AMERINGER, SUZANNE VIRGINIA COMMONWEALTH UNIVERSITY VA $228,750
Sickle Cell Disease 2016 FIC 5R21TW010252-02 Point-of-Delivery Prenatal Test Results through mHealth to Improve Birth Outcome EZEANOLUE, ECHEZONA UNIVERSITY OF NEVADA LAS VEGAS NV $165,638
Sickle Cell Disease 2016 NIDDK 1R01DK110104-01 Transcriptomic, therapeutic and genetic investigations of sickle cell nephropathy ASHLEY-KOCH, ALLISON DUKE UNIVERSITY NC $238,500
Sickle Cell Disease 2016 NHLBI 1R01HL134211-01 Malaria chemoprevention in children with sickle cell anemia in Western Kenya TAYLOR, STEVE DUKE UNIVERSITY NC $621,633
Sickle Cell Disease 2016 NHLBI 1R01HL133864-01 Novel role of smooth muscle B5 reductase in Sickle Cell Disease STRAUB, ADAM UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $595,680
Sickle Cell Disease 2016 NHLBI 1R01HL133574-01 Standardized Monitoring of Cellular Adhesion to Improve Clinical Care in Sickle Cell Disease LITTLE, JANE CASE WESTERN RESERVE UNIVERSITY OH $408,877
Sickle Cell Disease 2016 NHLBI 1R01HL133327-01 Sleep and Pain in Sickle Cell Disease HAYTHORNTHWAITE, JENNIFER JOHNS HOPKINS UNIVERSITY MD $775,356
Sickle Cell Disease 2016 NHLBI 1K23HL133446-01 Improving haploidentical stem cell engraftment in sickle cell disease using autologous mesenchymal stromal cells STENGER, ELIZABETH EMORY UNIVERSITY GA $187,812
Sickle Cell Disease 2016 NIDDK 1K08DK110448-01 A Genomics Approach to Gamma-Globin Regulation SHEEHAN, VIVIEN BAYLOR COLLEGE OF MEDICINE TX $145,403
Sickle Cell Disease 2016 NHLBI 1K08HL133493-01 Oxidative stress in vaso-occlusion pathophysiology of sickle cell disease WU, MELINDA OREGON HEALTH & SCIENCE UNIVERSITY OR $174,420
Sickle Cell Disease 2016 NHLBI 1K01HL133331-01 Protection against sickle cell disease nephropathy by nitrated fatty acids VITTURI, DARIO UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $160,756
Sickle Cell Disease 2016 NHLBI 1R21HL128871-01A1 Biomarker Profiles of Sickle Cell Disease SEBASTIANI, PAOLA BOSTON UNIVERSITY MEDICAL CAMPUS MA $123,375
Sickle Cell Disease 2016 NHLBI 1R21HL129033-01A1 Incidence of Malignancies in Californians with Sickle Cell Disease KEEGAN, THERESA UNIVERSITY OF CALIFORNIA AT DAVIS CA $121,361
Sickle Cell Disease 2016 NHLBI 2R44HL123670-03 Rapid LFIA blood test for SCD using highly specific monoclonal antibodies GEISBERG, MARK SILVER LAKE RESEARCH CORPORATION CA $500,000
Sickle Cell Disease 2016 NHLBI 2R44HL128670-02 Sickle SCAN(R) - A rapid, qualitative test to aid in the diagnosis of sickle cell disorders KIM, JASON BIOMEDOMICS, INC. NC $496,086
Sickle Cell Disease 2016 NHLBI 2R44HL123809-03 Developing a paper-based diagnostic test for sickle cell disease GIFFORD, SEAN HALCYON BIOMEDICAL, INC. TX $497,654
Sickle Cell Disease 2016 NIDDK 5F31DK105791-02 Effect of sickle cell trait status on diabetes prediction in African Americans LACY, MARY BROWN UNIVERSITY RI $43,576
Sickle Cell Disease 2016 NIMHD 1U24HL133948-01 Data Coordinating Center for Sickle Cell Disease Implementation Consortium (SCDIC) KRONER, BARBARA RESEARCH TRIANGLE INSTITUTE NC $100,000
Sickle Cell Disease 2016 NHLBI 1U24HL133948-01 Data Coordinating Center for Sickle Cell Disease Implementation Consortium (SCDIC) KRONER, BARBARA RESEARCH TRIANGLE INSTITUTE NC $823,986
Sickle Cell Disease 2016 NHLBI 1U01HL133964-01 Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina TANABE, PAULA DUKE UNIVERSITY NC $718,362
Sickle Cell Disease 2016 NHLBI 1U01HL133990-01 Implementation of a Sickle Cell Enhanced Novel Care Network in South Carolina (iSCENSC) MELVIN, CATHY MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $656,380
Sickle Cell Disease 2016 NHLBI 1U01HL133994-01 The Implementation of Cognitive Screening and Educational Support to Improve Outcomes of Adolescents and Young Adults with Sickle Cell Disease: From Clinic to the Community and Back KING, ALLISON WASHINGTON UNIVERSITY MO $685,234
Sickle Cell Disease 2016 NHLBI 1U01HL133996-01 RE-aiming at Hydroxyurea Adherence for Sickle cell with mHealth (RE-HASH) HANKINS, JANE ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $786,707
Sickle Cell Disease 2016 NHLBI 1U01HL133997-01 New York City Sickle Cell Implementation Science Consortium RICHARDSON, LYNNE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $779,271
Sickle Cell Disease 2016 NHLBI 1U01HL134004-01 Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease KUTLAR, ABDULLAH GEORGIA REGENTS UNIVERSITY GA $666,408
Sickle Cell Disease 2016 NHLBI 1U01HL134042-01 Improving Sickle cell care in Adolescents & Adults in Chicago (ISAAC) GORDEUK, VICTOR UNIVERSITY OF ILLINOIS AT CHICAGO IL $706,726
Sickle Cell Disease 2016 NHLBI 1U01HL134007-01 SC-Links - Linking the Sickle Cell Community, Providers and Systems to Improve Sickle Cell Disease Care VICHINSKY, ELLIOTT CHILDREN'S HOSPITAL & RES CTR AT OAKLAND CA $655,656
Sickle Cell Disease 2016 NHLBI 1F31HL134313-01 Improved Globin Expression Vectors for Gene Therapy of Human Hemoglobinopathies MORGAN, RICHARD UNIVERSITY OF CALIFORNIA LOS ANGELES CA $37,074
Sickle Cell Disease 2016 NHLBI 1F31HL134314-01 Biological Interventions to Improve Cognition in Children with Sickle Cell Disease HOOD, ANNA WASHINGTON UNIVERSITY MO $43,576
Sickle Cell Disease 2016 NICHD 1R01HD086978-01A1 iCanCope with Sickle Cell Disease PALERMO, TONYA SEATTLE CHILDREN'S HOSPITAL WA $504,137
Sickle Cell Disease 2016 NHLBI 1R01HL131414-01A1 Impaired Collateral Vessel Formation in Sickle Cell Disease TAYLOR, WILLIAM EMORY UNIVERSITY GA $605,307
Sickle Cell Disease 2016 FIC 1R21HD089791-01 Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda IDRO, RICHARD MAKERERE UNIVERSITY UGANDA $5,000
Sickle Cell Disease 2016 NICHD 1R21HD089791-01 Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda IDRO, RICHARD MAKERERE UNIVERSITY UGANDA $127,880
Sickle Cell Disease 2016 NHLBI 1R43HL134529-01 A prototype diagnostic for cellular fetal hemoglobin in sickle cell disease MOZELESKI, BRIAN MYOSYNTAX CORPORATION MA $224,986
Sickle Cell Disease 2016 NHLBI 2R44HL123059-02A1 Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy EMBURY, STEPHEN VANGUARD THERAPEUTICS, INC. CA $1,668,155
Sickle Cell Disease 2016 NIDDK 1R01DK111455-01 Targeting the NuRD complex for fetal globin induction MAEDA, TAKAHIRO BRIGHAM AND WOMEN'S HOSPITAL MA $388,215
Sickle Cell Disease 2016 NHLBI 1U01HL134696-01 Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells CHOU, STELLA CHILDREN'S HOSP OF PHILADELPHIA PA $1,019,455
Sickle Cell Disease 2016 NHLBI 1R03HL135454-01 Mitophagy as Potential Target in Sickle Cell Disease RIVERS, ANGELA UNIVERSITY OF ILLINOIS AT CHICAGO IL $79,950
Sickle Cell Disease 2016 NHLBI 3U01HL117664-04S1 Cannabinoid-based therapy and approaches to quantify pain in sickle cell disease GUPTA, KALPNA UNIVERSITY OF MINNESOTA MN $25,682
Sickle Cell Disease 2016 FIC 1K01TW010282-01A1 Role of MicroRNAs in malaria and sickle cell severity DRISS, ADEL MOREHOUSE SCHOOL OF MEDICINE GA $134,339
Sickle Cell Disease 2016 NIMHD 3R01MD009124-03S1 Hemoglobin Modifiers for Sickle Cell Disease Therapy SAFO, MARTIN VIRGINIA COMMONWEALTH UNIVERSITY VA $78,708
Sickle Cell Disease 2016 NHLBI 3R43HL123472-02S1 Developing a Point-of-Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings CHIMENTO, DAVID ROCKLAND IMMUNOCHEMICALS, INC. PA $40,000
Sickle Cell Disease 2016 OD 3U01HL117664-04S2 Cannabinoid-based therapy and approaches to quantify pain in sickle cell disease GUPTA, KALPNA UNIVERSITY OF MINNESOTA MN $100,000
Sickle Cell Disease 2016 NINDS 6R01NS096127-02 MRI-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia JORDAN, LORI VANDERBILT UNIVERSITY MEDICAL CENTER TN $321,099
Sickle Cell Disease 2016 NHLBI 3R01HL112633-05S1 von Willebrand Factor in Sickle Cell Disease Pathophysiology LOPEZ, JOSE PUGET SOUND BLOOD CENTER WA $148,808
Sickle Cell Disease 2016 NHLBI 1R56HL132906-01 A microfluidic platform to study sickle blood rheology WOOD, DAVID UNIVERSITY OF MINNESOTA MN $402,216
Sickle Cell Disease 2016 NIDDK 3R03DK109232-01S1 Identification of sequences and factors required for HbF repression BAUER, DANIEL CHILDREN'S HOSPITAL CORPORATION MA $49,092
Sickle Cell Disease 2016 NHLBI 3U24HL133948-01S1 Data Coordinating Center for Sickle Cell Disease Implementation Consortium (SCDIC) KRONER, BARBARA RESEARCH TRIANGLE INSTITUTE NC $50,947
Sickle Cell Disease 2016 NIAID 7R03AI123875-02 B1a Cell Function in Sickle Cell Disease HOLODICK, NICHOL WESTERN MICHIGAN UNIV SCHOOL OF MEDICINE MI $75,500
Sickle Cell Disease 2016 NIDDK 1R56DK104806-01A1 APOL1, sickle cell trait and chronic kidney disease in African Americans FRANCESCHINI, NORA UNIV OF NORTH CAROLINA CHAPEL HILL NC $300,000
Sickle Cell Disease 2016 NCI 1ZIDBC011517-04 Pediatric Oncology Branch Behavioral Science Core GLOD, JOHN NIH $1,218,420
Sickle Cell Disease 2016 NIA 1ZIAAG000675-10 Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort SCHLESSINGER, DAVID NIH $616,053
Sickle Cell Disease 2016 NIAID 1ZIAAI001000-10 Malaria Pathogenesis and Human Immunity FAIRHURST, RICK NIH $1,368,683
Sickle Cell Disease 2016 NCATS 1ZIATR000010-02 Repurposing an EU Therapeutic for Hemoglobinopathies HAUGABOOK, SHARIE NIH $1,765,116
Sickle Cell Disease 2016 NIDDK 1ZIADK025016-42 Pharmacological Control Of Human Hemoglobin Gene Expression SCHECHTER, ALAN NIH $97,308
Sickle Cell Disease 2016 NIDDK 1ZIADK025093-18 Nitric Oxide Metabolism and Transport SCHECHTER, ALAN NIH $437,884
Sickle Cell Disease 2016 NIDDK 1ZIADK025098-10 Research Studies of Erythropoiesis and Iron Biology. MILLER, JEFFERY NIH $714,231
Sickle Cell Disease 2016 NIDDK 1ZIADK025101-08 Regulation of Fetal Hemoglobin Production in Humans. MILLER, JEFFERY NIH $714,231
Sickle Cell Disease 2016 NIDDK 1ZIADK075008-11 Investigation of non-cirrhotic portal hypertension. HELLER, THEO NIH $153,103
Sickle Cell Disease 2016 NIDDK 1ZIAHL006007-09 Nonmyeloablative allogeneic PBSC in globin disorders TISDALE, JOHN NIH $570,763
Sickle Cell Disease 2016 NIDDK 1ZIAHL006008-09 A preclinical large animal model for globin gene transfer TISDALE, JOHN NIH $570,763
Sickle Cell Disease 2016 NIDDK 1ZIAHL006009-09 Isolation, characterization, and transplantation of candidate stem cells TISDALE, JOHN NIH $588,067
Sickle Cell Disease 2016 NIDDK 1ZIADK025021-41 Erythroid Differentiation and Treatment of Sickle Cell Anemia NOGUCHI, CONSTANCE NIH $227,976
Sickle Cell Disease 2016 NIDDK 1ZIADK029053-10 Screening for a Drug for Sickle Cell Disease EATON, WILLIAM NIH $2,156,307
Sickle Cell Disease 2016 NHGRI 1ZIAHG200394-03 Insights into Sickle Cell Trait and Sickle Cell Disease BONHAM, VENCE NIH $225,807
Sickle Cell Disease 2016 RMAP 3U01HG007459-03S1 Exploring Perspectives on Genomics and Sickle Cell Public Health Interventions WONKAM, AMBROISE UNIVERSITY OF CAPE TOWN SO AFR $50,000
Sickle Cell Disease 2016 NIAID 1ZIAAI001185-04 Roles of RNA-binding Proteins in Programming Gene Expression MULJO, STEFAN NIH $498,399
Sickle Cell Disease 2016 NHLBI 1ZIAHL006012-08 Prevalence and Prognosis of Pulmonary Hypertension in Adults with Sickle Cell TAYLOR, JAMES NIH $280,351
Sickle Cell Disease 2016 NHLBI 1ZIAHL006160-05 Genomic Determinants of Phenotypes of Sickle Cell Disease TAYLOR, JAMES NIH $654,153
Sickle Cell Disease 2016 NIBIB 1ZICEB000059-09 Infrared Imaging to Assess Endothelial Function in Sickle Cell Disease Patients GORBACH, ALEXANDER NIH $132,930
Sickle Cell Disease 2016 NIBIB 1ZICEB000060-09 Design of Infrared Imaging to Assess Vascular Tone in Peripheral Vascular Beds GORBACH, ALEXANDER NIH $132,930
Sickle Cell Disease 2016 NHLBI 1ZIAHL006191-03 Optimization of Fetal Hemoglobin Production to Prevent or Reverse Organ Damage and Improve Survival in Patients with Sickle Cell Disease FITZHUGH, COURTNEY NIH $2,646,917
Sickle Cell Disease 2016 NHLBI 1ZIAHL006196-02 Genetic Factors that Alter Vascular Function in Sickle Cell Disease ACKERMAN, HANS NIH $2,397,057
Sickle Cell Disease 2016 NHLBI 1ZIAHL006211-01 Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias FITZHUGH, COURTNEY NIH $882,306
Sickle Cell Disease 2016 NHLBI 26820140003B26800031-0-0-1 IGF::OT::IGF Logistical Support for Blood Diagnostics: Blood will tell! meeting to be held September 22-23, 2016 NO PI IDENTIFIED PALLADIAN PARTNERS, INC. MD $17,960


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer